Position Statements
Change to reporting of HbA 1c – what is happening and why - July 2009
NZSSD Executive Statement on Self Monitoring of Blood Glucose in non-insulin treated Type 2 Diabetes - February 2009
NZSSD Position Statement on Screening and Type 2 Diabetes - January 2009
NZSSD Position Statement on Insulin Pump Therapy - June 2008
NZSSD Executive Statement on Xenotransplantation in Type 1 Diabetes - June 2008
Royal College of Pathologists of Australia position statement on impaired fasting glucose (endorsed by NZSSD Executive) - February 2008
NZSSD Executive Statement on the use of HbA1c for diagnosis of diabetes - December 2007
Australian Diabetes Society position statement on Rosiglitazone (Avandia®) - May 2007
Management of Type 2 Diabetes - December 2003